Featured Research

from universities, journals, and other organizations

Increased Levels Of Certain Cytokines And Chemokines Predict Onset Of Rheumatoid Arthritis

Date:
June 30, 2009
Source:
European League Against Rheumatism
Summary:
Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis three years before the onset of symptoms, according to the results of a new study presented at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis (RA) three years before the onset of symptoms, according to the results of a new study presented at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

The results of the study showed that up-regulation of certain cytokines (specifically Th1, Th2 and Treg) involved in the growth and proliferation of various cells integral to the immune system, predicted which individuals go on to develop RA. Interestingly, post-disease onset, chemokines, stromal cell and angiogenic-related markers were important in differentiating up-regulation in those who had developed RA compared to findings in the same individual before symptoms of RA.

Cytokines and chemokines are small signalling molecules which are integral to the immune system, as they mediate and regulate immunity, inflammation, and the development of blood cells (haematopoiesis). In this study, several of these molecules, as well as some cytokine receptors, showed significantly increased levels before disease onset compared with controls (median 3.3 years before symptoms), indicating general immune activation (p<0.05-0.001)* and therefore a progression of disease activity.

The levels were seen to be particularly elevated in individuals identified as being ACPA- (anti-citrullinated peptide antibody) and RF- (rheumatoid factor) positive (both known risk factors for RA), and most of the concentrations increased further after disease onset. Notably, the concentration of interleukin 17 (IL-17, a cytokine which acts as a regulator of multiple immune functions) was found to be significantly higher before onset compared with post-diagnosis (p>0.01).

Prof Solbritt Rantapδδ Dahlqvist, of the University Hospital Umeε, Sweden, who led the study said: "Our findings add another important piece to the complex puzzle of pathophysiological processes responsible for the occurrence of RA. Understanding more about what happens in the body, to precipitate the onset of RA, could potentially contribute to the development of new strategies for the treatment and even prevention of this debilitating disease."

This nested case-control study (whereby new case controls were applied into a cohort that was defined before the study began, at a rate of 1 case:3 controls) was performed in individuals (n=86, 65 females, 21 males) who had donated blood to the Medical Biobank of Northern Sweden (median 3.3 years) before onset of disease; and matched controls (n=256, 191 females, 61 males) from the same Biobank. At the time of RA diagnosis (using American College of Rheumatology (ACR) criteria), 69 (52 females and 17 males) individuals donated blood samples.

30 cytokines, cytokine receptors and chemokines** were measured in plasma samples using multiplex detection kits from Bio-Rad analysed by a Bio-Plex Array Reader (Luminex200, Labmap™ system).

Notes

*The cytokines, cytokine receptors and chemokines that were increased prior to disease onset included: IL-1, IL-2, IL-6, IL-7, IL-1RA, TNF-VEGF, Th1 (IFN-, IL-12), Th2 (IL-4, Eotaxin), Treg (IL-10) and chemokines MCP-1 and MIP-1.

**The 30 cytokines, cytokine receptors and chemokines that were investigated in total for links to onset of RA included: IL-1ί, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, Eotaxin, basic FGF, G-CSF, GM-CSF, IFN-, IP-10, MCP-1, MIP-1, MIP-1, PDGF-BB, RANTES, TNF-, VEGF, MIG, MIF and IL-2R.


Story Source:

The above story is based on materials provided by European League Against Rheumatism. Note: Materials may be edited for content and length.


Cite This Page:

European League Against Rheumatism. "Increased Levels Of Certain Cytokines And Chemokines Predict Onset Of Rheumatoid Arthritis." ScienceDaily. ScienceDaily, 30 June 2009. <www.sciencedaily.com/releases/2009/06/090615094034.htm>.
European League Against Rheumatism. (2009, June 30). Increased Levels Of Certain Cytokines And Chemokines Predict Onset Of Rheumatoid Arthritis. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2009/06/090615094034.htm
European League Against Rheumatism. "Increased Levels Of Certain Cytokines And Chemokines Predict Onset Of Rheumatoid Arthritis." ScienceDaily. www.sciencedaily.com/releases/2009/06/090615094034.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) — After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) — A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) — Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) — Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins